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EDITORIAL Open Access
Benchmarking comes of age
Mark D. Robinson1* and Olga Vitek2*
The emergence of microarrays in the late 1990s, the
introduction of massively parallel nucleotide sequencing
in the mid 2000s, and the continuous improvement of
mass spectrometric and imaging technologies trans-
formed the way we practice biology. The new technolo-
gies produce datasets of ever increasing complexity and
size, and in turn stimulate massive advances in all areas
of data science. A vast repertoire of bespoke statistical
and computational methods and software tools now
process, interpret, and condense these datasets, to help
generate and test new hypotheses and extract actionable
insight.
This diversity of the methods and tools presents its
own challenge. Alternative views of a problem give rise
to multiple distinct tools for a same general purpose.
Even small differences in data preprocessing or analysis
in these tools can impact the downstream biological
conclusions, and even produce contradictory results.
The fast pace of biotechnology and data science makes it
increasingly difficult to choose a right technology, and a
right data analysis method or tool, for the scientific
question at hand. These challenges feed broader misun-
derstandings among the consumers of the scientific re-
search in the age of concerns for irreproducibility,
science skepticism, and fake news.
This special issue takes the view that rigorous and
exhaustive benchmarking is an effective way to address
these challenges. Since not all methods and tools stand
the test of time [1–3], they must be vetted beyond the
original publication [4]. In post-genomic biology, such
vetting includes documenting the limitations of data
produced by various biotechnologies, the fidelity of the
computational transformations and preprocessing of the
data, the validity of statistical modeling assumptions,
and the availability (when legally allowed) of the open
source code and data. Benchmarking efforts [5, 6] aim to
perform such vetting in a transparent manner, and high-
light the gaps in methodology and in implementations.
Proper and conclusive benchmarking of methods and
tools has its own methodological challenges, and Genome
Biology has long been an active proponent of benchmark-
ing research [7, 8]. As the first articles from this special
issue now appear in print, several known and new themes
addressing the methodological challenges of benchmark-
ing have emerged.
In some cases, benchmarking is made challenging by
the sheer number of approaches available. For example,
Kosugi et al. [9] investigated 69 structural variation detec-
tion algorithms; Abdelaal et al. [10] evaluated 22 single
cell classification methods across 27 datasets; and Ziele-
zinksi et al. [11] tested 74 alignment methods. The high
variation in installability of bioinformatics tools alone
observed by Mangul et al. [12] made such comparisons a
daunting task.
Beyond considering the set of relevant methods for a
particular task, an important aspect of benchmarking is
the choice of reference datasets [13]. Most often, bench-
marks combine synthetic and experimental datasets. On
the one hand, simulations provide an opportunity to
scrutinize methods across a wide set of conditions, such
as the level of informativeness of a covariate used to
weight the false discovery budget [14] or to the true
underlying evolutionary selection scenarios [15], while
relying on ground truth. Such simulations must demon-
stratively retain the key properties of the experimental
data [13]. On the other hand, the experimental datasets
must contain some notion of a ground truth, established
at “arm’s length” from the methods evaluated. For ex-
ample, Wick et al. relied on an accurate reference genome
sequence [16] base calling of Nanopore data; Abdelaal
et al. used pre-sorted cell populations or manual annota-
tion to compare cell-level classification methods [10]; and
Mendoza et al. evaluated the reconstruction of metabolic
networks using manually curated models [17].
Given reference datasets with ground truth and a set of
methods to test, the choice of metrics for method evalu-
ation is non-trivial, and often context-specific. For
example, the performance of base calling can be reported
at either read level or consensus level, their relative im-
portance depending on the application [16]. Another
example is F1 score, a classical metric for evaluating cell
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type assignment [10]. However, the metric does not
characterize the performance by cell type, and benchmar-
kers balance detail and resolution at their discretion. Men-
doza et al. created a suite of 22 ad hoc features to evaluate
the properties of tools for reconstructing metabolic net-
works [17]. Finally, although run times are somewhat of
peripheral significance, they become important when
many competing methods perform well.
Although the benchmarks in this issue are rigorous and
comprehensive, they only reflect the state of the art at the
current point in time. But the scientific advances do not
stop. More methodological research and infrastructure
must be developed in the future for dynamic addition of
new methods, reference datasets, and metrics to the
benchmarks. This will enable an early integration of an
emerging benchmark into the method developers commu-
nity, will avoid the “method explosion” as in the analysis
of single cell data [18] or the “evaluation explosion” where
every new method is evaluated differently [11], and will
preserve the relevance of the benchmarks in time.
The objectives of dynamic evaluation are facilitated by
the availability of open data and code. For example, Duò
and Soneson made available data and software for add-
ing new clustering algorithms directly to existing figures
[19]. Furthermore, the broader benchmarking commu-
nity could adopt practices of challenge-based bench-
marks, such as containerization and code validation [20].
These practices may be particularly valuable even for
benchmarks that do not require controlled “model-to-
data” access, but still benefit from cloud computing and
continuous “frictionless” integration [20]. Extensibility
with new datasets and metrics will also be welcome.
Such openness will increase the credibility of the bench-
marking process and will maximize its impact.
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